サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1771591

米国のヘルスケアにおける人工知能市場規模、シェア、動向分析レポート：コンポーネント別、用途別、技術別、最終用途別、セグメント予測、2025年～2033年

U.S. Artificial Intelligence In Healthcare Market Size, Share & Trends Analysis Report By Component (Software, Solution, Services), By Application (Robot Assisted Surgery, Clinical Trials), By Technology, By End Use, And Segment Forecasts, 2025 - 2033

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.50円
米国のヘルスケアにおける人工知能市場規模、シェア、動向分析レポート：コンポーネント別、用途別、技術別、最終用途別、セグメント予測、2025年～2033年
出版日: 2025年06月17日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

米国のヘルスケアにおける人工知能市場のサマリー

米国のヘルスケアにおける人工知能市場規模は2024年に132億6,000万米ドルと推計され、2025年から2033年にかけて36.76%のCAGRで成長すると予測されます。

堅牢なデジタルヘルスインフラストラクチャーとAI技術への投資、慢性疾患の蔓延、個別化および遠隔ヘルスケアソリューションに対する需要の増加が市場成長を促進する要因となっています。

加えて、政府の支援策、ヘルスケア専門家の不足、業務効率化のニーズの高まりなども市場成長をさらに後押しする要因となっています。例えば、2024年10月、Amazon One Medicalは、独自の電子カルテシステム「1Life」に統合されたAIツールを発表し、患者ケアの強化と臨床医の管理負担の軽減を図っています。

糖尿病、心血管疾患、がんなどの慢性疾患の有病率の増加と急速な高齢化は、米国におけるAI対応ヘルスケアソリューションの需要を大きく促進しています。例えば、CDCによると、米国人の10人に6人が少なくとも1つの慢性疾患に罹患しています。また、人口問題研究所によると、2050年までに65歳以上の人口は8,200万人になると予想されており、高齢化人口は大幅に増加すると予測されています。この人口動態の変化は、AIが重要な役割を果たす可能性のある長期ケア、継続的な健康モニタリング、効果的な疾病管理を強化する機会をもたらします。

さらに、同国のヘルスケアインフラは、高度なデジタルヘルスエコシステム、電子カルテ（EHR）の広範な採用、広範なデータリポジトリ、最先端の医療ITシステムによって特徴付けられています。大手ヘルステック企業はヘルスケアAIソリューションに多額の投資を行っており、新興企業はベンチャーキャピタルから多額の資金を集め続けています。例えば、2025年2月、世界のヘルステック企業であるHarrison.aiは、AIを活用した医療診断およびワークフローソリューションを推進するため、シリーズCで1億1,200万米ドルの資金を調達し、米国での拠点を拡大した。

さらに、遠隔患者モニタリングのための遠隔医療ソリューションの採用が増加していることが、市場の成長をさらに後押ししています。AIシステムは、患者データ分析を自動化し、リアルタイムの意思決定を促進し、従来の臨床環境外での患者関与を改善することにより、バーチャルケアを強化します。例えば、2024年12月、AIを搭載した遠隔医療プラットフォームのプロバイダーであるVSee Healthは、Tele911と提携し、初のバーチャル救急部門を設立しました。ERの過密状態を解消し、救急医療サービス（EMS）の人員不足に対処するのが目的です。このような取り組みにより、特に遠隔地や十分なサービスを受けていない地域の患者にとって、ヘルスケア提供がより身近で便利になります。そのため、AIを活用した遠隔医療ソリューションの需要が高まり、市場の成長に貢献します。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国のヘルスケアにおける人工知能市場の変数、動向、範囲

  • 市場系統の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
  • 米国のヘルスケアにおける人工知能市場の分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
  • ケーススタディ
  • 規制の枠組み

第4章 米国のヘルスケアにおける人工知能市場：コンポーネントの推定・動向分析

  • 定義と範囲
  • セグメントダッシュボード
  • 米国のヘルスケアにおける人工知能市場のコンポーネント変動分析
  • 米国のヘルスケアにおける人工知能市場の規模と動向分析（コンポーネント別、2021～2033年）
    • ソフトウェアソリューション
    • ハードウェア
    • サービス

第5章 米国のヘルスケアにおける人工知能市場：用途の推定・動向分析

  • セグメントダッシュボード
  • 米国のヘルスケアにおける人工知能市場の用途変動分析
  • 米国のヘルスケアにおける人工知能市場（AI）の規模と動向分析（用途別、2021～2033年）
    • ロボット支援手術
    • バーチャルアシスタント
    • 管理ワークフローアシスタント
    • 接続型医療機器
    • 医療画像診断
    • 臨床試験
    • 不正行為検出
    • サイバーセキュリティ
    • 投与量誤差の削減
    • 精密医療
    • 医薬品の発見と開発
    • ライフスタイル管理と遠隔患者モニタリング
    • ウェアラブル
    • その他

第6章 米国のヘルスケアにおける人工知能市場：技術の推定・動向分析

  • セグメントダッシュボード
  • 米国のヘルスケアにおける人工知能市場の技術変動分析
  • 米国のヘルスケアにおける人工知能市場（AI）の規模と動向分析（技術別、2021～2033年）
    • 機械学習
    • NLP
    • コンピュータービジョン
    • コンテキストアウェアコンピューティング

第7章 米国のヘルスケアにおける人工知能市場：最終用途の推定・動向分析

  • セグメントダッシュボード
  • 米国のヘルスケアにおける人工知能市場の最終用途変動分析
  • 米国のヘルスケアにおける人工知能市場（AI）の規模と動向分析（最終用途別、2021～2033年）
    • 病院・ヘルスケア・ヘルスケア提供者
    • ヘルスケア支払者
    • 製薬・バイオテクノロジー企業
    • 患者
    • その他

第8章 競合情勢

  • 企業/競合の分類
  • 戦略マッピング
  • 企業市況分析、2024年
  • 企業プロファイル/上場企業
    • IBM Watson Health
    • Microsoft Corporation
    • Google Health
    • NVIDIA Corporation
    • Amazon Web Services（AWS）
    • Tempus AI
    • Aidoc
    • Eko Health Inc.
    • Hinge Health
    • Abridge
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 U.S. Artificial Intelligence in Healthcare Market, By Components, 2021 - 2033 (USD Million)
  • Table 3 U.S. Artificial Intelligence in Healthcare Market, By Application, 2021 - 2033 (USD Million)
  • Table 4 U.S. Artificial Intelligence in Healthcare Market, By Technology, 2021 - 2033 (USD Million)
  • Table 5 U.S. Artificial Intelligence in Healthcare Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 U.S. Artificial Intelligence in Healthcare Market: Market outlook
  • Fig. 5 U.S. Artificial Intelligence in Healthcare Market: Segment outlook
  • Fig. 6 U.S. Artificial Intelligence in Healthcare Market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 U.S. Artificial Intelligence in Healthcare Market driver impact
  • Fig. 9 U.S. Artificial Intelligence in Healthcare Market restraint impact
  • Fig. 10 U.S. Artificial Intelligence in Healthcare Market: Component outlook and key takeaways
  • Fig. 11 U.S. Artificial Intelligence in Healthcare Market: Component movement analysis
  • Fig. 12 Software solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Hardware market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 U.S. Artificial Intelligence in Healthcare Market: Application outlook and key takeaways
  • Fig. 16 U.S. Artificial Intelligence in Healthcare Market: Application movement analysis
  • Fig. 17 Robot assisted surgery market estimates and forecast, 2021 - 2033
  • Fig. 18 Virtual assistants market estimates and forecast, 2021 - 2033
  • Fig. 19 Administrative workflow assistants market estimates and forecast, 2021 - 2033
  • Fig. 20 Connected medical devices market estimates and forecast, 2021 - 2033
  • Fig. 21 Medical imaging & diagnostics market estimates and forecast, 2021 - 2033
  • Fig. 22 Clinical trials market estimates and forecast, 2021 - 2033
  • Fig. 23 Fraud detection market estimates and forecast, 2021 - 2033
  • Fig. 24 Cybersecurity market estimates and forecast, 2021 - 2033
  • Fig. 25 Dosage error reduction market estimates and forecast, 2021 - 2033
  • Fig. 26 Precision medicine market estimates and forecast, 2021 - 2033
  • Fig. 27 Drug discovery & developments market estimates and forecast, 2021 - 2033
  • Fig. 28 Lifestyle management & remote patient monitoring market estimates and forecast, 2021 - 2033
  • Fig. 29 Wearables market estimates and forecast, 2021 - 2033
  • Fig. 30 Others market estimates and forecast, 2021 - 2033
  • Fig. 31 U.S. Artificial Intelligence in Healthcare Market: Technology outlook and key takeaways
  • Fig. 32 U.S. Artificial Intelligence in Healthcare Market: Technology movement analysis
  • Fig. 33 Machine learning market estimates and forecast, 2021 - 2033
  • Fig. 34 NLP market estimates and forecast, 2021 - 2033
  • Fig. 35 Computer vision market estimates and forecast, 2021 - 2033
  • Fig. 36 Context-aware computing market estimates and forecast, 2021 - 2033
  • Fig. 37 U.S. Artificial Intelligence in Healthcare Market: End Use outlook and key takeaways
  • Fig. 38 U.S. Artificial Intelligence in Healthcare Market: End Use movement analysis
  • Fig. 39 Hospitals & healthcare providers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 40 Healthcare payers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 41 Pharmaceutical & biotechnology companies market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 42 Patients market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 43 Others market estimates and forecast, 2021 - 2033 (USD Million)
目次
Product Code: GVR-4-68040-627-6

U.S. Artificial Intelligence In Healthcare Market Summary

The U.S. Artificial Intelligence in healthcare market size was estimated at USD 13.26 billion in 2024 and is projected to grow at a CAGR of 36.76% from 2025 to 2033. Robust digital health infrastructure and investments in AI technology, the growing prevalence of chronic diseases, and the increasing demand for personalized and remote healthcare solutions are factors driving market growth.

In addition, supportive government initiatives, a shortage of healthcare professionals, and the growing need for operational efficiency are some other factors propelling market growth further. For instance, in October 2024, Amazon One Medical launched AI tools integrated into its proprietary electronic health record system, 1Life, to enhance patient care and reduce clinician administrative burden.

The increasing prevalence of chronic diseases such as diabetes, cardiovascular conditions, and cancer, coupled with a rapidly aging population, is significantly driving the demand for AI-enabled healthcare solutions in the United States. For instance, according to the CDC, 6 in 10 Americans are affected by at least one chronic disease. In addition, the aging demographic is projected to grow substantially, with the Population Reference Bureau estimating that by 2050, the population aged 65 or older is expected to be 82 million. This demographic shift presents an opportunity to enhance long-term care, continuous health monitoring, and effective disease management, where AI is potentially significant.

Furthermore, the country's healthcare infrastructure is characterized by an advanced digital health ecosystem, widespread adoption of electronic health records (EHR), extensive data repositories, and cutting-edge health IT systems. Major health tech firms have made significant investments in healthcare AI solutions, while startups continue to attract substantial venture capital funding. For instance, in February 2025, Harrison.ai, a global health tech company, expanded its U.S. footprint with USD 112 million in Series C funding to advance its AI-powered medical diagnostic and workflow solutions.

Moreover, the increasing adoption of telehealth solutions for remote patient monitoring drives market growth further. AI systems enhance virtual care by automating patient data analysis, facilitating real-time decision-making, and improving patient engagement outside traditional clinical settings. For instance, in December 2024, VSee Health, anAI-powered telehealth platform provider, partnered with Tele911 to create the first virtual emergency department. The aim is to reduce ER overcrowding and address emergency medical services (EMS) staffing shortages. Such initiatives enable healthcare delivery to be more accessible and convenient, especially for patients in remote or underserved areas. Thus, they increase the demand for AI-powered telehealth solutions and contribute to market growth.

U.S. Artificial Intelligence In Healthcare Market Report Segmentation

This report forecasts revenue growth at country-level and provides an analysis of industry trends in each of the sub segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the U.S. artificial intelligence in healthcare market report based on component, application, technology, and end use.

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software Solutions
    • AI platform
    • Application Program Interface (API)
    • Machine Learning Framework
    • AI Solutions
    • On premise
    • Cloud based
  • Hardware
    • Processor
    • MPU (memory protection unit)
    • FPGA (Field-programmable gate array)
    • GPU (Graphics processing unit)
    • ASIC (Application-specific integrated circuit)
    • Memory (RAM ROM)
    • Network
    • Adapter
    • Interconnect
    • Switch
  • Services
    • Deployment & Integration
    • Support & Maintenance
    • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Robot Assisted Surgery
  • Virtual Assistants
  • Administrative Workflow Assistants
  • Connected Medical devices
  • Medical Imaging & Diagnostics
  • Clinical Trials
  • Fraud Detection
  • Cybersecurity
  • Dosage Error Reduction
  • Precision medicine
  • Drug discovery & development
  • Lifestyle management & remote patient monitoring
  • Wearables
  • Others
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Machine Learning
    • Deep learning
    • Supervised
    • Unsupervised
    • Others
  • NLP
    • Smart Assistance
    • OCR (Optical Character Recognition)
    • Auto Coding
    • Text analytics
    • Speech analytics
    • Classification and categorization
  • Computer Vision
  • Context-Aware Computing
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Healthcare providers
  • Healthcare payers
  • Pharmaceutical & Biotechnology Companies
  • Patients
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Deployment Mode
    • 1.2.2. Monitoring Type Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. Artificial Intelligence in Healthcare Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Demand for Healthcare Efficiency
      • 3.2.1.2. Increase in Chronic Diseases and Geriatric Population
      • 3.2.1.3. Advancements in AI and Cloud Infrastructure
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Implementation Costs
      • 3.2.2.2. Data Privacy and Security Concerns
  • 3.3. Market Opportunity Analysis
  • 3.4. Market Challenges Analysis
  • 3.5. U.S. Artificial Intelligence in Healthcare Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
      • 3.5.2.4. Environmental Landscape
      • 3.5.2.5. Legal Landscape
      • 3.5.2.6. Social Landscape
  • 3.6. Case Study
  • 3.7. Regulatory Framework

Chapter 4. U.S. Artificial Intelligence in Healthcare Market: Component Estimates & Trend Analysis

  • 4.1. Definitions and Scope
  • 4.2. Segment Dashboard
  • 4.3. U.S. Artificial Intelligence in Healthcare Market Movement Analysis
  • 4.4. U.S. Artificial Intelligence in Healthcare Market Size & Trend Analysis,
  • 4.5. by Component, 2021 to 2033 (USD Million)
    • 4.5.1. Software Solutions
      • 4.5.1.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 4.5.1.1.1. AI platform
          • 4.5.1.1.1.1. Market estimates and forecast 2021 to 2033 (USD Million)
          • 4.5.1.1.1.2. Application Program Interface (API)
            • 4.5.1.1.1.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
          • 4.5.1.1.1.3. Machine Learning Framework
            • 4.5.1.1.1.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 4.5.1.1.2. AI Solutions
          • 4.5.1.1.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
          • 4.5.1.1.2.2. On premise
            • 4.5.1.1.2.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
          • 4.5.1.1.2.3. Cloud based
            • 4.5.1.1.2.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 4.5.2. Hardware
      • 4.5.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 4.5.2.1.1. Processor
          • 4.5.2.1.1.1. Market estimates and forecast 2021 to 2033 (USD Million)
          • 4.5.2.1.1.2. MPU (memory protection unit)
            • 4.5.2.1.1.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
          • 4.5.2.1.1.3. FPGA (Field-programmable gate array)
            • 4.5.2.1.1.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
          • 4.5.2.1.1.4. GPU (Graphics processing unit)
            • 4.5.2.1.1.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
          • 4.5.2.1.1.5. ASIC (Application-specific integrated circuit)
            • 4.5.2.1.1.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 4.5.2.1.2. Memory
          • 4.5.2.1.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 4.5.2.1.3. Network
          • 4.5.2.1.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
          • 4.5.2.1.3.2. Adapter
            • 4.5.2.1.3.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
          • 4.5.2.1.3.3. Interconnect
            • 4.5.2.1.3.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
          • 4.5.2.1.3.4. Switch
            • 4.5.2.1.3.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 4.5.3. Services
      • 4.5.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 4.5.3.1.1. Deployment & Integration
          • 4.5.3.1.1.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 4.5.3.1.2. Support & Maintenance
          • 4.5.3.1.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 4.5.3.1.3. Others (Consulting, Compliance management etc.)
          • 4.5.3.1.3.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. U.S. Artificial Intelligence in Healthcare Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Artificial Intelligence in Healthcare Market Application Movement Analysis
  • 5.3. U.S. Artificial Intelligence in Healthcare Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
    • 5.3.1. Robot Assisted Surgery
      • 5.3.1.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.3.2. Virtual Assistants
      • 5.3.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.3.3. Administrative Workflow Assistants
      • 5.3.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.3.4. Connected Medical Devices
      • 5.3.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.3.5. Medical Imagining & Diagnosis
      • 5.3.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.3.6. Clinical Trials
      • 5.3.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.3.7. Fraud Detection
      • 5.3.7.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.3.8. Cybersecurity
      • 5.3.8.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.3.9. Dosage Error Reduction
      • 5.3.9.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.3.10. Precision medicine
      • 5.3.10.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.3.11. Drug discovery & development
      • 5.3.11.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.3.12. Lifestyle management & remote patient monitoring
      • 5.3.12.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.3.13. Wearables
      • 5.3.13.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.3.14. Others
      • 5.3.14.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. U.S. Artificial Intelligence in Healthcare Market: Technology Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Artificial Intelligence in Healthcare Market Technology Movement Analysis
  • 6.3. U.S. Artificial Intelligence in Healthcare Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
    • 6.3.1. Machine Learning
      • 6.3.1.1. Market estimates and forecast 2021 to 2033 (USD million)
        • 6.3.1.1.1. Deep Learning
          • 6.3.1.1.1.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 6.3.1.1.2. Supervised
          • 6.3.1.1.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 6.3.1.1.3. Unsupervised
          • 6.3.1.1.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 6.3.1.1.4. Others (Reinforcement learning, Semi supervised)
          • 6.3.1.1.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 6.3.2. NLP
      • 6.3.2.1. Market estimates and forecast 2021 to 2033 (USD million)
        • 6.3.2.1.1. Smart Assistance
          • 6.3.2.1.1.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 6.3.2.1.2. OCR (Optical Character Recognition)
          • 6.3.2.1.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 6.3.2.1.3. Auto Coding
          • 6.3.2.1.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 6.3.2.1.4. Text analytics
          • 6.3.2.1.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 6.3.2.1.5. Speech analytics
          • 6.3.2.1.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
        • 6.3.2.1.6. Classification and categorization
          • 6.3.2.1.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 6.3.3. Computer Vision
      • 6.3.3.1. Market estimates and forecast 2021 to 2033 (USD million)
    • 6.3.4. Context-aware computing
      • 6.3.4.1. Market estimates and forecast 2021 to 2033 (USD million)

Chapter 7. U.S. Artificial Intelligence in Healthcare Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Artificial Intelligence in Healthcare Market End Use Movement Analysis
  • 7.3. U.S. Artificial Intelligence in Healthcare Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
    • 7.3.1. Hospitals & Healthcare & Healthcare providers
      • 7.3.1.1. Market estimates and forecast 2021 to 2033 (USD million)
    • 7.3.2. Healthcare payers
      • 7.3.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 7.3.3. Pharmaceutical & Biotechnology Companies
      • 7.3.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 7.3.4. Patients
      • 7.3.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 7.3.5. Others
      • 7.3.5.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. IBM Watson Health
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Microsoft Corporation
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Google Health
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. NVIDIA Corporation
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Amazon Web Services (AWS)
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Tempus AI
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Aidoc
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Eko Health Inc.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Hinge Health
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Abridge
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives